Premier, Inc. (NASDAQ:PINC) General Counsel Sells $249,730.68 in Stock

Premier, Inc. (NASDAQ:PINC) General Counsel David L. Klatsky sold 10,982 shares of the business’s stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $22.74, for a total transaction of $249,730.68. Following the sale, the general counsel now owns 76,093 shares of the company’s stock, valued at $1,730,354.82. This trade represents a 12.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link.

Premier Price Performance

PINC stock opened at $23.30 on Friday. The firm has a 50 day simple moving average of $19.40 and a two-hundred day simple moving average of $20.52. The stock has a market cap of $2.13 billion, a PE ratio of -232.93 and a beta of 0.54. Premier, Inc. has a one year low of $17.23 and a one year high of $23.56.

Premier Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Sunday, June 15th. Shareholders of record on Sunday, June 1st will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 3.61%. The ex-dividend date is Friday, May 30th. Premier’s dividend payout ratio (DPR) is presently -840.00%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on PINC shares. Robert W. Baird lowered their price target on Premier from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Canaccord Genuity Group raised their price target on shares of Premier from $19.00 to $22.00 and gave the company a “hold” rating in a research report on Thursday. Finally, Piper Sandler reduced their price objective on shares of Premier from $21.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Seven equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $20.60.

Hedge Funds Weigh In On Premier

A number of large investors have recently added to or reduced their stakes in PINC. Van ECK Associates Corp boosted its holdings in Premier by 28.0% during the 4th quarter. Van ECK Associates Corp now owns 2,041 shares of the company’s stock valued at $43,000 after acquiring an additional 446 shares during the period. SRS Capital Advisors Inc. grew its holdings in shares of Premier by 157.8% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock worth $27,000 after purchasing an additional 786 shares during the last quarter. Brooklyn Investment Group increased its stake in shares of Premier by 61,750.0% in the fourth quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock worth $26,000 after buying an additional 1,235 shares during the period. Russell Investments Group Ltd. raised its holdings in Premier by 40.4% during the 4th quarter. Russell Investments Group Ltd. now owns 4,371 shares of the company’s stock valued at $93,000 after buying an additional 1,257 shares during the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in Premier by 297.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock valued at $40,000 after buying an additional 1,427 shares during the period. Hedge funds and other institutional investors own 74.41% of the company’s stock.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.